학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 61건 | 목록 1~20
Raqamli iqtisodiyotni hozirgi hayotimizdagi o‘rni: «Yangi O‘zbekiston: Moliyaviy hisobotning xalqaro standartlarini joriy etishda muvaffaqiyatli xalqaro tajriba» 16 dekabr, 2022 yil. 270 Annotatsiya: Bu maqolada siz raqamli iqtisodiyot haqida quyidagi ma’lumotlarni olishingiz mumkin. “Raqamli iqtisodiyot haqida qisqacha malumot”, “Raqamli iqtisodiyotning afzalliklari”, “Raqamli iqtisodiyotning salbiy tomonlari”, “Rivojlangan davlatlar asosida raqamli iqtisodiyot”, “O‘zbekistonda raqamli iqtisodiyotni rivojlantirish yo‘llari”. Kalit so ‘ zlar: Digital economy,Deverloped countries,Information technology, Economic indicator, Technology infrastructure. So‘nggi vaqtlarda “Digital Economy” tushunchasi juda ko‘p marotaba ishlatilm- oqda. Darhaqiqat, ko‘plab rivojlangan mamlakatlarda digital economy ularning rivojlanishiga sezilarli darajada ta’sir o‘tkazmoqda. Keling, avvalo “Digital Economy”ning kelib chiqishi tarixini o‘rganaylik.Digital Economy bu uzoq vaqtlar oldin ya’ni 1995-yil Massachusets universtiteti olimi Nikolas Negroponte tomonida aniqlab berilgan.Olim axborot-kommunikatsi-ya texnologiyalarini intensiv rivojlanishi ortidan eski iqtisodiyotni yangi iqtosodiy-otga o‘tishda qanday o‘zgarishlar ro‘y berishi mumkinligini aytib bergan. Digital Economy - bu xo‘jalik faoliyatini yuritishdir, bunda ishlab chiqarish va xizmat ko‘rsatishdagi asosiy omili raqamlar ko‘rinshidagi ma’lumotlar bo‘lib, kat-ta hajmdagi axborotlarni qayta ishlash va shu qayta ishlash natijasini tahlil qilish yordamida har xil turdagi ishlab chiqarish, xizmat ko‘rsatish, texnologiyalar, qur-ilmalar, saqlash, mahsulotlarni yetkazib berishda oldingi tizimdan samaraliroq ye-chimlar tatbiq qilishdir. Boshqacha qilib aytganda, raqamli iqtisodiyot bu onlayn xizmatlar ko‘rsatish, elektron to‘lovlar amalga oshirish, internet savdo va boshqa turdagi sohalarni raqamli komputer texnologiyalarini rivojlanishi bilan bog‘langan faoliyat. Digital Economy raqamli texnologiyalarga asoslangan, elektron biznes va elektron tijorat bilan bog‘langan, raqamli tovar va xizmatlar ishlab chiqarayotgan va taqdim etilayotgan iqtisodiy xizmat va tovarlar uchun hisob-kitoblar elektron pul orqali amalga oshiriladigan iqtisodiy faolyatdir. Axborot texnologiyalarining rivojlanishi va tatbiq qilinishi evaziga kundalik hay- otimizda juda ko‘plab qulayliklar paydo bo‘lmoqda. RAQAMLI IQTISODIYOTNI HOZIRGI HAYOTIMIZDAGI O‘RNI https://doi.org/10.47689/STARS.univer-s i t y - 5 - p p 2 6 8 - 2 7 1 G‘AYBULLAYEV SARVAR O‘KTAM O‘G‘LI O‘zMUJF, o‘qituvchi JARASHEVA GO‘ZAL BAHODIR QIZI, O‘zMUJF, talabaE-mail: dilshodbekshodlikov@gmail.com STARS International University 271 Tajribalar natijasida digital economy rivojlangan va rivojlanayotgan davlatlarda teng huquqli qoidalarini, o‘yinning barcha ishtirokchilari uchun bir xil imkonyat be-radi. Bularga AQSH, Buyuk Britanya, Daniya, Finlandiya,Singapur,J anubiy Korya, Gonkong, Norvegiya, Shvetsiya va Shvetsariya kiradi. Demak, digital economy rivojlanishi uchun davlat hammaga teng sharoit yaratib berishi, iloji boricha bozor qonun-qoidalari, shartnomalar shaffof bo‘lishi, qonunlar bozor talabidan kelib chiqqan holda (ya’ni bozordagi rivojlanish tendensiyalarini oldindan aniqlay olishi va kerakli normativ hujjatlarni qabul qilishi) o‘yin ishtirok-chilari uchun erkinlik berishi zarurdir. Zamonaviy ilm-fanning cho‘qqisi yuqori texnologiyalarda, raqamli olamda ko‘zga tashlanadi. Zero, digital economy aql bovar qilmas katta hajmda raqamli ma’lumo-tlarni to‘plashda va to‘laqonli taqdim etishni davom etmoqda. 2022-yilda global IP trafik hajmi 150 700 Gbit/s (solishtirish uchun 2017-yil 45 000 Gbit/s) chiqi-shi ko‘zda tutilayotgan edi. Shuningdek, texnologiya olamida ko‘pchilikka ma’lum bo‘lgan “Microsoft” korparatsiyasi asoschisi Bill Geytsning bir fikri bor. “Tez orada Yer sharida faqat ikki tur kompaniyalari mavjud bo‘ladi. Birinchisi, Internet orqali biznes qiluvchi va ikkinchisi, biznesdan chiqqan kompanyalardir”. Xususan, Digital Economy afzalliklari va salbiy tomonlari haqida to‘xtaladigan bo‘lsak. Albatta, Information technology texnologiyalarning rivojlanishi, zamonaviy tex- nologiyalarning hayotimizga tatbiq etilishi har bir inson hayotida ko‘plab ijobiy im-konyatlar berishi mumkin. Raqamli texnologiyalar rivojlanishi ortidan inson, unga kerakli xizmatdan tezroq foydalanishi, internet orqali o‘ziga zarur mahsulotlarni arzon sotib olish bilan yetarlicha pul mablag‘larini tejash mumkin. Shuningdek, information technology quyidagi afzalliklarni berishi mumkin:•ishlab chiqarishda mehnat samaradorligini oshirish; •ishlab chiqarishdagi xarajatlarning kamayishi; •kompaniyalarning raqobatdoshligini o‘sishi;•yangi ish o‘rnini yaratilishi;•yangi zamonaviy kasblarning paydo bo‘lishi;•kambag‘allikni yengishning yangicha usuli.Bu raqamli iqtisodiyotni bor-yo‘g‘i bir nechta afzalliklaridir.Digital Economy rivojlanishini bizning kundalik hayotimizga ijobiy ta’sir qiladi, oddiy foydalanuvchiga ko‘plab qo‘shimcha imkonyatlar beradi va qolaversa, bo-zorning o‘sishi va rivojlanishini ta’minlab berishi mumkin. Raqamli iqtisodiyot keltirib chiqarishi mumkin bo‘lgan xavflardanbirinchi o‘rinda Kiber hujum xavfidir. Bunda asosan shaxsiy hujjatlarni va shaxsiy ijtimoyi-iqtisodiy huquqlarini oshkor qilish kabi muammolarni amalga oshiradi. Axborot texnologiyalari va kommunikatsiyalarini rivojlantirishda digital econo- my alohida faolyat turini emas, balki ishbilarmonlik, sanoat ob’yektlari, xizmatlarda axborot texnologiyalaridan faol foydalanishni anglatadi. Agar oddiy iqtisodiyotda moddiy buyumlar asosiy resurs hisoblansa, raqamli iqtisodiyotda bu qayta ishlan-adigan hamda uzatiladigan axborot, ma’lumotlar hisoblanadi. Nufuzli xalqaro tashkilotlar olib borgan tahlillarga ko‘ra digital economy yalpi ichki mahsulotni kamida 30 foizga oshiradi, shuningdik, xufyona iqtisodiyotga bar-ham beradi. «Yangi O‘zbekiston: Moliyaviy hisobotning xalqaro standartlarini joriy etishda muvaffaqiyatli xalqaro tajriba» 16 dekabr, 2022 yil. 272 O‘zbekistonda “Raqamli O‘zbekiston-2030” dasturining ishlab chiqilishi va hayotga tatbiq etilishi, eng avvalo, puxta va mukammal tashkiliy-huquqiy mex-anizmlarni shakllantirish, qolaversa, innovatsion g‘oyalar, texnologiyalar va ishlan-malarni joriy etish bo‘yicha davlat organlari va tadbirkorlik sub’yektlarining uz-viy hamkorligini ta’minlash, barcha soha va tarmoqlarda ishlab chiqarish va xi-zmat ko‘rsatishni raqamli texnologiyalar bilan qamrab olish, bu borada zamonaviy bilimlarni chuqur egallagan, intellektual salohiyatli kadrlarni yetishtirish, shu orqali mamlakatda “axborotlashgan jamiyat” muhitini yaratishga xizmat qiladi. Xulosa: Aql-zakovat va ilm — taraqqiyot qanotidir. Zamonaviy ilm-fanning cho‘qqisi yuqori texnologiyalarda, raqamli olamda ko‘zga tashlanadi. To‘rtinchi sa-noat inqilobi taraqqiyotning yangi ko‘rinishi-“Digital Economy” boshlanganini an-glatadi. Foydalanilgan adabiyotlar: 1.Akramovich N. A. THE PRIORITY OF USING INNOVATIVE TECHNOLOGIES IN THE AGRICULTURAL EDUCATION SYSTEM //Journal of Academic Research and Trends in Educational Sciences. – 2022. – Т. 1. – №. 10. – С. 185-191. 2.Хакимов О. М., Курбанов З. Х., Мухаммедов Ф. Реализация возможностей получения легких наполнителей на основе меньше пластиковых почв в на-шей республике //Science and Education. – 2021. – Т. 2. – №. 5. – С. 176-181. 3.Мухтаров Б. А., Ортиков Ё. Ю. Культурное и экономическое развитие ту- ризма в Узбекистане //Молодой ученый. – 2016. – №. 14. – С. 375-378. 4.Rashidov U., Rashidov A. Assessment of Costs For the Quality of Logistics Activities //INTERNATIONAL JOURNAL OF BUSINESS DIPLOMACY AND ECONOMY. – 2022. – Т. 1. – №. 3. – С. 39-43. 5.Ҳосилмуродов И., Султоналиева Г. Тафаккур услубининг фалсафий-мето- дологик таҳлили //Zamonaviy innovatsion tadqiqotlarning dolzarb muammolari va rivojlanish tendensiyalari: yechimlar va istiqbollar. – 2022. – Т. 1. – №. 1. – С. 549-551. 6.Nodira T. INNOVATIVE MANAGEMENT IN THE DEVELOPMENT OF THE HIGHER EDUCATION SYSTEM //Journal of Academic Research and Trends in Educational Sciences. – 2022. – Т. 1. – №. 10. – С. 346-351. 7.Ali o‘g‘li A. O. STATISTICAL STUDY OF DIRECT MAINTENANCE OF SMALL BUSINESS ACTIVITIES IN THE REGIONS //EPRA International Journal of Economic and Business Review (JEBR). – 2022. – Т. 10. – №. 6. – С. 30-33. 8.Норбеков, Х., & Туйчиева, Н. (2022). Формирование конкурентных преи- муществ компании. Zamonaviy Innovatsion Tadqiqotlarning Dolzarb Muammolari Va Rivojlanish Tendensiyalari: Yechimlar Va Istiqbollar, 1(1), 589–592. Retrieved from https://inlibrary.uz/index.php/zitdmrt/article/view/5351 9.Nasirov B. U., Boltaeva M. J. Genesis And Transformation Of The Public Catering System In Uzbekistan During The Soviet Period //Turkish Online Journal of Qualitative Inquiry (TOJQI) Volume. – Т. 12. – С. 5834-5841. 10.Uchkun S., Dilshod N. PROCESS OF IDENTIFYING THE SIGNIFICANT ACCOUNTS IN THE REVENUE CYCLE //Journal of marketing, business and management. – 2022. – Т. 1. – №. 1. – С. 32-36. STARS International University 273 11.Nodira T., Rashid X. PROBLEMS OF INNOVATION MANAGEMENT IN THE HIGHER EDUCATION SYSTEM //Web of Scientist: International Scientific Research Journal. – 2022. – Т. 3. – №. 11. – С. 155-164. 12.Abdusattarovich M. B. CALCULATING ECONOMIC EFFICIENCY IN THE DIGITAL ECONOMY IN UZBEKISTAN //Web of Scientist: International Scientific Research Journal. – 2022. – Т. 3. – №. 10. – С. 1189-1194. 13.Khakimov O. SOCIAL GOALS OF STUDENTS IN HIGHER EDUCATION // International Bulletin of Applied Science and Technology. – 2022. – Т. 2. – №. 11. – С. 55-59. 14.Nosirovich A. N. The Methodology of Preparation of Students of Vocational Schools and Colleges for Technical Creative Activity //PSYCHOLOGY AND EDUCATION. – 2021. – Т. 58. – №. 2. – С. 1470-1485. 15.Alimov N., Gulrukh F. Dependence of psychological maturity on the strength of family relationships //Eurasian Journal of Humanities and Social Sciences. – 2022. – Т. 6. – С. 38-41. 16.Nosirovich A. N. The Methodology of Preparation of Students of Vocational Schools and Colleges for Technical Creative Activity //PSYCHOLOGY AND EDUCATION. – 2021. – Т. 58. – №. 2. – С. 1470-1485. 17.Burkhanovna, K. D., Alisherovich, M. R., & Ugli, N. B. U. (2021). Communication as the main source of personality development. ACADEMICIA: An International Multidisciplinary Research Journal, 11(5), 75-80. 18.Nosirovich, A. N., & Umarovich, N. B. (2022). CYBERSPACE IN THE REAL WORLD. Journal of Academic Research and Trends in Educational Sciences, 1(10), 410-414. 19.Burkhanovna, K. D., Alisherovich, M. R., & Ugli, N. B. U. (2021). Communication as the main source of personality development. ACADEMICIA: An International Multidisciplinary Research Journal, 11(5), 75-80. 20.Nosirovich, A. N., & Umarovich, N. B. (2022). CYBERSPACE IN THE REAL WORLD. Journal of Academic Research and Trends in Educational Sciences, 1(10), 410-414.
Academic Journal
Новый Узбекистан: успешный международный опыт внедрения международных стандартов финансовой отчетности. 1:270-273
Academic Journal
Academic Journal
2022-yil, 3-son (133/1) ANIQ FANLAR SERIYASI. 4:1-10
Academic Journal
Atanackovic D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Luetkens T; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Schneider D; Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD, USA.; Hu P; Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD, USA.; Wang X; Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD, USA.; Shetty AC; Institute for Genome Sciences (IGS), School of Medicine, University of Maryland Baltimore, Baltimore, MD, USA.; Tallon L; Institute for Genome Sciences (IGS), School of Medicine, University of Maryland Baltimore, Baltimore, MD, USA.; Patel I; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Singh R; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Gebru E; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Mulatu R; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Omili D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Yamoah D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Fan X; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Matsangos A; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Lesho P; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Dietze KA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Fromowitz AA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Hankey KG; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Dahiya S; Stanford University, Stanford, CA, USA.; Yared JA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Hardy NM; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Kallen ME; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Badros A; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Rapoport AP; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Kocoglu MH; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Kline K; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Luetkens T; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Kallen ME; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Chen W; Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Ahmad H; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.; Omili D; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Iraguha T; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Gebru E; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Fan X; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Miller A; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Dishanthan N; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Baker JM; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Dietze KA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Hankey KG; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Yared JA; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Hardy NM; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Rapoport AP; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Dahiya S; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Stanford University, Stanford, CA, USA.; Atanackovic D; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA. datanackovic@som.umaryland.edu.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA. datanackovic@som.umaryland.edu.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Academic Journal
Kline K; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Chen W; Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Kallen ME; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Omili D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Fan X; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Iraguha T; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Gebru E; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Dishanthan N; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Baker JM; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Dietze KA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Yared JA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Hankey K; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Dahiya S; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Blood and Marrow Transplant Program, Stanford University, Stanford, CA, USA.; Niederhaus SV; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.; Dunleavy K; Hematology Program, George Washington University, Washington, DC, USA.; Hardy NM; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Luetkens T; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.; Rapoport AP; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Atanackovic D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Academic Journal
Vander Mause ER; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.; Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Department of Pharmaceutics & Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT, USA.; Baker JM; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.; Dietze KA; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.; Radhakrishnan SV; Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.; Iraguha T; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Omili D; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Davis P; Division of Experimental and Clinical Pathology, ARUP Laboratories, Salt Lake City, UT, USA.; Department of Pathology, University of Utah, Salt Lake City, UT, USA.; Chidester SL; Preclinical Research Resource, Huntsman Cancer Institute, Salt Lake City, UT, USA.; Modzelewska K; Preclinical Research Resource, Huntsman Cancer Institute, Salt Lake City, UT, USA.; Panse J; Department of Oncology, Hematology, Hemostaseology, and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany.; Marvin JE; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Olson ML; Department of Pathology, University of Utah, Salt Lake City, UT, USA.; Steinbach M; Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Ng DP; Department of Pathology, University of Utah, Salt Lake City, UT, USA.; Lim CS; Department of Pharmaceutics & Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT, USA.; Atanackovic D; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.; Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Department of Medicine and Transplant/Cell Therapy Program, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Luetkens T; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.; Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Department of Medicine and Transplant/Cell Therapy Program, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Kocoglu MH; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Luetkens T; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Bork JT; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.; Baddley J; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD.; Divison of Infectious Diseases, University of Maryland School of Medicine, Baltimore, MD.; Omili D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Gebru E; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Mulatu R; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Yamoah D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Iraguha T; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Fan X; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Lesho P; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Yousaf M; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Baker JM; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Dietze KA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Hankey KG; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Badros A; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Yared JA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Rapoport AP; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Hardy NM; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Atanackovic D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Academic Journal
Atanackovic D; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA; Department of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, USA. Electronic address: datanackovic@som.umaryland.edu.; Iraguha T; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Omili D; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Avila SV; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Fan X; Department of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, USA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Kocoglu M; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Gebru E; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Baker JM; Department of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, USA.; Dishanthan N; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Dietze KA; Department of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, USA.; Oluwafemi A; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA; Department of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, USA.; Hardy NM; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Yared JA; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Hankey K; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Dahiya S; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA; Stanford University, Stanford, California, USA.; Rapoport AP; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.; Luetkens T; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA; Department of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE
Academic Journal
Kathari YK; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Ahmad H; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD.; Kallen ME; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD.; Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD.; Omili D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Iraguha T; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Clement J; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Pham L; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD.; Khalid M; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD.; Fan X; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Gebru E; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Lesho P; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Park E; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Dishanthan N; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Baker JM; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Dietze KA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Hankey KG; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.; Badros A; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Yared JA; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Dahiya S; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Stanford University, Stanford, CA.; Hardy NM; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Kocoglu H; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Luetkens T; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD.; Rapoport AP; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD.; Atanackovic D; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD. datanackovic@som.umaryland.edu.
Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Omili, D.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어